NSTL国家科技图书文献中心

1. Radiopharmaceuticals Adverse Events Management NSTL国家科技图书文献中心

Martinez, Ana Agudo | Hernandez, Gertrudis...... - 《Current radiopharmaceuticals》 - 2025,18(1) - 45～55 - 共11页

摘要： intravenously. Adverse events that may induce both adverse | protocols for the management of such adverse* events among* | recognition of adverse* events associated with* | electronic form to enhance adverse* event registration. The* | safety and diagnostic accuracy. Adverse* reactions are*

关键词： Adverse reactions | radiopharmaceutical-drug interaction | radiopharmaceutical extravasations | adverse events management | patient safety | diagnostic accuracy

2. Comprehensive evaluation of leuprorelin-associated adverse events: insights from FDA adverse event reporting system NSTL国家科技图书文献中心

Tang, Xiao | Zheng, Fuchun ... - 《Expert opinion on drug safety》 - 2025,24(3) - 355～364 - 共10页

摘要： adverse events. Statistical methods such as Proportional | adverse event reports from the FDA Adverse Event | FAERS data from Q1 2004 to Q1 2024. Adverse* drug* | events (ADEs) related to leuprorelin were identified | BackgroundLeuprorelin, a gonadotropin

关键词： Leuprorelin | adverse events | FAERS | real-world data analysis | pharmacovigilance

3. Disproportionality analysis of adverse events associated with asfotase alfa: a post-marketing study using the FDA Adverse Event Reporting System NSTL国家科技图书文献中心

Wang, Wen | Wang, Zhe ... - 《Expert opinion on drug safety》 - 2025,24(4) - 435～443 - 共9页

摘要： (HPP). Limited real-world data on its adverse events | using the U.S. FDA's Adverse* Event Reporting System* | BackgroundAsfotase alfa (AA) is an FDA | -approved enzyme replacement therapy for hypophosphatasia | (AEs) exist. This study evaluates AA-related AEs

关键词： Asfotase alfa | adverse events | pharmacovigilance | FDA Adverse Event Reporting System (FAERS) | real-world data

4. Adverse events in psychotherapy randomized controlled trials: A systematic review NSTL国家科技图书文献中心

Klatte, Rahel | Strauss, Bernhard ... - 《Psychotherapy research》 - 2025,35(1/2) - 84～99 - 共16页

摘要： adverse events (AEs) of psychotherapy. Method: This | mental disorders. Harmful events, e.g., AEs, number of | Objective: Although evidence for benefits of | psychotherapy is substantial, less is known about potential | harm. Therefore, we systematically summarized

关键词： adverse events | harm | psychotherapy | RCT | systematic review

5. Investigating bleeding adverse events associated with BTK inhibitors in the food and drug administration adverse event reporting system (FAERS) NSTL国家科技图书文献中心

Li, Xianlin | Shang, Nan ... - 《Expert opinion on drug safety》 - 2025,24(2) - 183～192 - 共10页

摘要： adverse events (AEs) resulting from the treatment of B | Administration's Adverse* Event Reporting System (FAERS* | BackgroundThis study analyzed the bleeding | -cell lymphoma with Bruton tyrosine kinase (BTK | ) inhibitors, according to reports in the US Food and Drug

关键词： BTK inhibitors | B-cell malignancies | adverse events | bleeding | FAERS

6. Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data NSTL国家科技图书文献中心

Ge, Wukun | Yan, Yingyan ... - 《Journal of Alzheimer's disease》 - 2025,103(3) - 844～855 - 共12页

摘要： days (range: 1-1283) for all adverse* events, with* | using data from the FDA Adverse* Event Reporting System* | most frequently reported adverse* event (200 cases* | neurological events* occurring slightly later (median: 42 days* | Background Lecanemab, a novel monoclonal

关键词： adverse events | Alzheimer's disease | disproportionality analysis | FAERS | lecanemab | pharmacovigilance

7. In-Hospital Adverse Events in Older Patients with Hip Fracture: A Multicenter Retrospective Study NSTL国家科技图书文献中心

Lessard, Justine | Isaac, Chartelin Jea...... - 《Journal of the American Medical Directors Association》 - 2025,26(2) - 105384～105384 - 共6页

摘要： outcome was a composite of any adverse* events defined as* | adverse event: extended LOS (n = 1106; 24.2%), death (n | %). Risk factors of any in-hospital adverse event | adverse event (AOR, 0.87; 95% CI, 0.76-0.99 | fracture suffered from an adverse* event. Aged >= 75 years*

关键词： Hip fracture | older adults | trauma | adverse events

8. Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database NSTL国家科技图书文献中心

Sun, Yu | Xu, Tao ... - 《Expert opinion on drug safety》 - 2025,24(2) - 233～239 - 共7页

摘要： adverse events (AEs) associated with abrocitinib in a | Administration Adverse* Event Reporting System (FAERS) for this* | BackgroundAtopic dermatitis (AD) is a common | chronic inflammatory skin disease. Janus kinase (JAK | ) modulates cytokines involved in AD pathophysiology, and

关键词： Abrocitinib | FAERS | adverse events | signal detection | pharmacovigilance

9. Variations in Adverse Events Typology Following E-Cigarette Use: The Role of Preexisting Medical Conditions NSTL国家科技图书文献中心

Cuomo, Raphael E. | Purushothaman, Vidya... - 《Substance use & misuse》 - 2025,60(1/4) - 421～429 - 共9页

摘要： study examines the immediate adverse* events following* | conditions that may increase the risk of adverse events | preexisting conditions and 48 adverse* events, adjusting for* | risks for similar adverse* events, including mouth* | Background: Electronic cigarettes (e

关键词： E-cigarettes | adverse events | risk factors | medical comorbidities | prevalence

10. Oral and cutaneous immune‐related adverse events in cancer patients: Prevalence and overall survival NSTL国家科技图书文献中心

Osias Vieira Oliveir... | Ivana Lameiras Gibbo...... - 《Oral diseases》 - 2025,31(1) - 278～285 - 共8页

摘要： of cutaneous and oral immune‐related adverse events | Abstract Objectives To assess the prevalence | (irAEs) in cancer patients, risk factors for its | development, and overall survival (OS). Materials and | Methods This retrospective observational study which

关键词： Adverse reactions | radiopharmaceutical-drug interaction | radiopharmaceutical extravasations | adverse events management | patient safety | diagnostic accuracy

摘要： adverse events. Statistical methods such as Proportional | adverse event reports from the FDA Adverse Event | FAERS data from Q1 2004 to Q1 2024. Adverse* drug* | events (ADEs) related to leuprorelin were identified | BackgroundLeuprorelin, a gonadotropin

关键词： Leuprorelin | adverse events | FAERS | real-world data analysis | pharmacovigilance

摘要： (HPP). Limited real-world data on its adverse events | using the U.S. FDA's Adverse* Event Reporting System* | BackgroundAsfotase alfa (AA) is an FDA | -approved enzyme replacement therapy for hypophosphatasia | (AEs) exist. This study evaluates AA-related AEs

关键词： Asfotase alfa | adverse events | pharmacovigilance | FDA Adverse Event Reporting System (FAERS) | real-world data

摘要： adverse events (AEs) of psychotherapy. Method: This | mental disorders. Harmful events, e.g., AEs, number of | Objective: Although evidence for benefits of | psychotherapy is substantial, less is known about potential | harm. Therefore, we systematically summarized

关键词： adverse events | harm | psychotherapy | RCT | systematic review

摘要： adverse events (AEs) resulting from the treatment of B | Administration's Adverse* Event Reporting System (FAERS* | BackgroundThis study analyzed the bleeding | -cell lymphoma with Bruton tyrosine kinase (BTK | ) inhibitors, according to reports in the US Food and Drug

关键词： BTK inhibitors | B-cell malignancies | adverse events | bleeding | FAERS

摘要： days (range: 1-1283) for all adverse* events, with* | using data from the FDA Adverse* Event Reporting System* | most frequently reported adverse* event (200 cases* | neurological events* occurring slightly later (median: 42 days* | Background Lecanemab, a novel monoclonal

关键词： adverse events | Alzheimer's disease | disproportionality analysis | FAERS | lecanemab | pharmacovigilance

摘要： outcome was a composite of any adverse* events defined as* | adverse event: extended LOS (n = 1106; 24.2%), death (n | %). Risk factors of any in-hospital adverse event | adverse event (AOR, 0.87; 95% CI, 0.76-0.99 | fracture suffered from an adverse* event. Aged >= 75 years*

关键词： Hip fracture | older adults | trauma | adverse events

摘要： adverse events (AEs) associated with abrocitinib in a | Administration Adverse* Event Reporting System (FAERS) for this* | BackgroundAtopic dermatitis (AD) is a common | chronic inflammatory skin disease. Janus kinase (JAK | ) modulates cytokines involved in AD pathophysiology, and

关键词： Abrocitinib | FAERS | adverse events | signal detection | pharmacovigilance

摘要： study examines the immediate adverse* events following* | conditions that may increase the risk of adverse events | preexisting conditions and 48 adverse* events, adjusting for* | risks for similar adverse* events, including mouth* | Background: Electronic cigarettes (e

关键词： E-cigarettes | adverse events | risk factors | medical comorbidities | prevalence

摘要： of cutaneous and oral immune‐related adverse events | Abstract Objectives To assess the prevalence | (irAEs) in cancer patients, risk factors for its | development, and overall survival (OS). Materials and | Methods This retrospective observational study which

关键词： immune checkpoint inhibitors | immune‐related adverse events | immunotherapy | oral adverse events | oral toxicity

4008-161-200 800-990-8900

国家科技图书文献中心

摘要： intravenously. Adverse events that may induce both adverse | protocols for the management of such adverse events among | recognition of adverse events associated with | electronic form to enhance adverse event registration. The | safety and diagnostic accuracy. Adverse reactions are

关键词： Adverse reactions | radiopharmaceutical-drug interaction | radiopharmaceutical extravasations | adverse events management | patient safety | diagnostic accuracy

摘要： adverse events. Statistical methods such as Proportional | adverse event reports from the FDA Adverse Event | FAERS data from Q1 2004 to Q1 2024. Adverse drug | events (ADEs) related to leuprorelin were identified | BackgroundLeuprorelin, a gonadotropin

关键词： Leuprorelin | adverse events | FAERS | real-world data analysis | pharmacovigilance

摘要： (HPP). Limited real-world data on its adverse events | using the U.S. FDA's Adverse Event Reporting System | BackgroundAsfotase alfa (AA) is an FDA | -approved enzyme replacement therapy for hypophosphatasia | (AEs) exist. This study evaluates AA-related AEs

关键词： Asfotase alfa | adverse events | pharmacovigilance | FDA Adverse Event Reporting System (FAERS) | real-world data

摘要： adverse events (AEs) of psychotherapy. Method: This | mental disorders. Harmful events, e.g., AEs, number of | Objective: Although evidence for benefits of | psychotherapy is substantial, less is known about potential | harm. Therefore, we systematically summarized

关键词： adverse events | harm | psychotherapy | RCT | systematic review

摘要： adverse events (AEs) resulting from the treatment of B | Administration's Adverse Event Reporting System (FAERS | BackgroundThis study analyzed the bleeding | -cell lymphoma with Bruton tyrosine kinase (BTK | ) inhibitors, according to reports in the US Food and Drug

关键词： BTK inhibitors | B-cell malignancies | adverse events | bleeding | FAERS

摘要： days (range: 1-1283) for all adverse events, with | using data from the FDA Adverse Event Reporting System | most frequently reported adverse event (200 cases | neurological events occurring slightly later (median: 42 days | Background Lecanemab, a novel monoclonal

关键词： adverse events | Alzheimer's disease | disproportionality analysis | FAERS | lecanemab | pharmacovigilance

摘要： outcome was a composite of any adverse events defined as | adverse event: extended LOS (n = 1106; 24.2%), death (n | %). Risk factors of any in-hospital adverse event | adverse event (AOR, 0.87; 95% CI, 0.76-0.99 | fracture suffered from an adverse event. Aged >= 75 years

关键词： Hip fracture | older adults | trauma | adverse events

摘要： adverse events (AEs) associated with abrocitinib in a | Administration Adverse Event Reporting System (FAERS) for this | BackgroundAtopic dermatitis (AD) is a common | chronic inflammatory skin disease. Janus kinase (JAK | ) modulates cytokines involved in AD pathophysiology, and

关键词： Abrocitinib | FAERS | adverse events | signal detection | pharmacovigilance

摘要： study examines the immediate adverse events following | conditions that may increase the risk of adverse events | preexisting conditions and 48 adverse events, adjusting for | risks for similar adverse events, including mouth | Background: Electronic cigarettes (e

关键词： E-cigarettes | adverse events | risk factors | medical comorbidities | prevalence

摘要： of cutaneous and oral immune‐related adverse events | Abstract Objectives To assess the prevalence | (irAEs) in cancer patients, risk factors for its | development, and overall survival (OS). Materials and | Methods This retrospective observational study which

关键词： immune checkpoint inhibitors | immune‐related adverse events | immunotherapy | oral adverse events | oral toxicity

4008-161-200 800-990-8900

国家科技图书文献中心

摘要： adverse events. Statistical methods such as Proportional | adverse event reports from the FDA Adverse Event | FAERS data from Q1 2004 to Q1 2024. Adverse* drug* | events (ADEs) related to leuprorelin were identified | BackgroundLeuprorelin, a gonadotropin

摘要： (HPP). Limited real-world data on its adverse events | using the U.S. FDA's Adverse* Event Reporting System* | BackgroundAsfotase alfa (AA) is an FDA | -approved enzyme replacement therapy for hypophosphatasia | (AEs) exist. This study evaluates AA-related AEs

摘要： adverse events (AEs) resulting from the treatment of B | Administration's Adverse* Event Reporting System (FAERS* | BackgroundThis study analyzed the bleeding | -cell lymphoma with Bruton tyrosine kinase (BTK | ) inhibitors, according to reports in the US Food and Drug

摘要： days (range: 1-1283) for all adverse* events, with* | using data from the FDA Adverse* Event Reporting System* | most frequently reported adverse* event (200 cases* | neurological events* occurring slightly later (median: 42 days* | Background Lecanemab, a novel monoclonal

摘要： outcome was a composite of any adverse* events defined as* | adverse event: extended LOS (n = 1106; 24.2%), death (n | %). Risk factors of any in-hospital adverse event | adverse event (AOR, 0.87; 95% CI, 0.76-0.99 | fracture suffered from an adverse* event. Aged >= 75 years*

摘要： adverse events (AEs) associated with abrocitinib in a | Administration Adverse* Event Reporting System (FAERS) for this* | BackgroundAtopic dermatitis (AD) is a common | chronic inflammatory skin disease. Janus kinase (JAK | ) modulates cytokines involved in AD pathophysiology, and

摘要： study examines the immediate adverse* events following* | conditions that may increase the risk of adverse events | preexisting conditions and 48 adverse* events, adjusting for* | risks for similar adverse* events, including mouth* | Background: Electronic cigarettes (e